1 Min Read
Dec 18 (Reuters) - Oxford BioMedica PLC : * Announces option agreement with GlaxoSmithkline * Grants GSK an option for the development of up to six candidates targeting
rare orphan diseases * Source text
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.